Antibiotic lock: In vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37 °C

Hemodialysis International

Volumn 14, Issue 3, 2010, Pages 322-326

  Battistella, Marisa ^a,b   Vercaigne, Lavern M ^c,d   Cote, Dennis ^c   Lok, Charmaine E ^a,e  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d Manitoba Renal Program   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Catheters; Citrate; Dialysis; Gentamicin; Lock

Indexed keywords

CITRATE SODIUM; GENTAMICIN;

ANTIBIOTIC LOCK; ANTISEPSIS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIALYSIS CATHETER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFECTION PREVENTION; STORAGE TEMPERATURE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CITRATES; DRUG STABILITY; GENTAMICINS; HUMANS; RENAL DIALYSIS; TEMPERATURE;

EID: 77955014685     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2010.00440.x     Document Type: Article

References (34)

1. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006, 48((Suppl 1)):S248-S273. Vascular Access Work Group
2. Besarab A, Adam M, Amatucci S. Unraveling the realities of vascular access: The Network 11 experience. Adv Ren Replace Therp 2000, 7((Suppl 1)):S65-S70.
3. Moist L, Trpeski L, Na Y, Lok CE. Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk: Data from the Canadian Organ Replacement Registry 2001-2004. CJASN 2008, 3:1726-1732.
4. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2008, U.S. Renal Data System., Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
5. Jindal K, Chan CT, Deziel C. Chapter 4: vascular access. J Am Soc Nephrol 2006, 17((Suppl 1)):S16-S23.
6. Tokars JI, Miller ER, Stein G. New national surveillance system for hemodialysis-associated infections: Initial results. Am J Infect Control 2002, 30:288-295.
7. Schaubel DE, Fenton SSA. Trends in mortality rates on hemodialysis in Canada, 1981-1997. Kidney Int 2000, 57:S66-S73.
8. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000, 58:1758-1764.
9. O'Grady NP, Alexander M, Dellinger EP. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002, 9:1-29.
10. Marr KASD, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997, 127:275-280.
11. Shaffer D. Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: Management by guidewire exchange. Am J Kidney Dis 1995, 25:593-596.
12. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999, 34:1114-1124.
13. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999, 10:1045-1049.
14. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J Parenter Enteral Nutr 1988, 12:185-189.
15. Krishnasami Z, Carlton D, Bimbo L. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002, 61:1136-1142.
16. Capdevila JA, Segarra A, Planes AM. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 1993, 8:231-234.
17. Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: Effect of bacterial pathogen. Nephrol Dial Transplant 2004, 19:1237-1244.
18. Vardhan A, Davies J, Daryanani I, Crowe A, McClelland P. Treatment of haemodialysis catheter-related infections. Nephrol Dial Transplant 2002, 17:1149-1150.
19. Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters-an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant 2007, 22:471-476.
20. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM. Trisodium citrate 4%- an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 2007, 22:477-483.
21. MacRae JM, Dojcinovic I, Ognjenka D. Citrate 4% versus Heparin and the Redcuion of Thrombosis Study (Charts). Clin J Am Soc Nephrol 2008, 3:369-374.
22. Battistella M, Walker S, Law S, Lok C. Antibiotic lock: in vitro stability of vancomycin and 4% sodium citrate stored in dialysis catheters at 37C. Hemo Int 2009, 13:322-328.
23. Wentworth DW, Kim FJ, Lentino JR. Citrate may be the anticoagulant of choice to prevent clotting of antibiotic locks used in vascular access devices. J Am Soc Nephrol 1999, 10:222A.
24. Wazny L, Walker S, Moist L. Visual compatibility of gentamicin sulfate and 4% sodium citrate solutions. Am J Health Syst Pharm 2005, 62:1548-1550.
25. Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ. Antibiotic-heparin lock: In vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 2000, 20:394-399.
26. Weijmer M, van den Dorpel MA, Van deVen PJG. Randomized, Clinical Trail Comparison of Trisdoium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialyiss Patients. J Am Soc Neprhol 2005, 16:2769-2777.
27. Bell AL, Jayaraman R, Vercaigne LM. Effect of ethanol/trisodium citrate lock on the mechanical properties of carbothane hemodialysis catheters. Clin Nephrol 2006, 65:342-348.
28. Lu PL, Tsai JC, Chiu YW. Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and tehir family members. Nephrol Dial Transplant 2008, 23:1659-1665.
29. Alexandraki I, Bhatt U, Plott D, Nakman N. Hemodialysis vascular catheter-related bacteremia: Five year epidemiological shift in orgnaism isolates. J Am Soc Nephrol 2005, 16:453A. (abstract)
30. Weijmer M, Debets-Ossenkopp Y, van de Vondervoort F, ter Wee P. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 2002, 17:2189-2195.
31. Bardoux P, Bles N, Lemaire S. Combined effect of pH and concentration on the activiteis of gentamicin and oxacillin against Staphylococcus aureus in pharmcodynamic models of extracellular and intracellular infections. J Antimicrob Chemother 2007, 59:246-253.
32. Moran J, Doss S, Pedan A. Effective strategy for preventing tunneled hemodialysis catheter infection and thrombosis, F-P01592 ASN 2008; Philadelphia, PA (abstract)
33. Pervez A, Ahmed M, Ram S. Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J Vasc Access 2002, 3:108-113.
34. Dogra GK, Herson H, Hutchison B. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomized controled study. J Am Soc Nephrol 2002, 13:2133-2139.